Overview:
The bioprocess technology
market share is expected to reach USD 19.84 Billion by 2032 at 7.1% CAGR
during the forecast period 2023-2032.
Bioprocess Technology Market Size is
witnessing at present an unprecedented growth due to revolutionary changes
effected upon it by technological advancements. The impact is aptly backed by
demands generated by the healthcare sector. The global Bioprocess Technology
market is expected to witness significant growth during the forecast period
(2017-2022), reveals Market Research Future (MRFR) in a detailed analysis of
the said market. Bioprocess Technology involves deriving living cells or
components and obtains desired results to boost pharmaceuticals or chemical
sector. The report incorporates multiple factors that can promote Bioprocess
Technology market further such as its growing use in developing new drugs &
treatments, food processing, thermal design of biomedical devices, and
effective application in pollution control & global warming. An in-depth
review of the segments has also been included for a better understanding of the
bioprocess technology consultants market in coming years.
However,
the regulatory process often delays the approval of new drugs which can
increase the production cost by a significant margin. This can put a leash on
the expected Bioprocess Technology Market Share, growth during the forecast period.
Bioprocess
Technology Market Overview and Information, by Type (flow cytometry, cell
culture, cell expansion, cell line development, virus infiltration), by
Application (biopharmaceuticals, specialty products and industrial chemicals,
environmental management aid), by End Users (hospitals, research Centers,
medical institutions)
Key Players:
Some
of the Bioprocess Technology Market Players profiled in this report are
Merck Millipore (Germany),
Thermo Fisher Scientific, Inc. (U.S.),
Becton,
Dickinson and Company (U.S.),
Danaher Corporation (U.S.),
Lonza Group AG (Switzerland),
Sartorius Stedim Biotech S.A (France),
Corning, Inc. (U.S.),
Bio-Rad Laboratories (U.S.),
Charles River Laboratories (U.S.), and
others.
Segmentation:
The
global Bioprocess Technology
Market Outlook can be segmented by type, application, and end-users.
- Type-based
segmentation of the Bioprocess Technology market
includes cell culture, cell expansion, flow cytometry, cell line
development, and virus infiltration. Cell culture has diverse
application in various sectors which gives it much traction, and it has
become a necessary part in treating chronic diseases.
- Application-wise,
the Bioprocess Technology market comprises
biopharmaceuticals, specialty products, industrial chemicals, and
environment management aid. Biopharmaceuticals’ prosperous run is to
continue owing to its widespread functioning area as it has impacted
common medicines to chronic diseases. Furthermore, petrochemicals can
propel the demand for industrial chemicals in coming
- Based
on end-users, the Bioprocess Technology market consists
hospitals, research labs and centers, medical institutions and others.
Research labs and centers to gain the most owing to private and government
investments in the field.
Regional Analysis:
Region-specific
analysis of the Bioprocess Technology Market Insights Report includes North
America, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).
North
America’s growth can be attributed to its ability to fetch the maximum revenue
in the global market. Infrastructural superiority can be considered as a boon
for the regional market. Furthermore, healthcare is receiving much funding
which is directly impacting the Bioprocess Technology market by generating
demand for pharmaceutical drugs. Governments and private investors are also
spending much in search for new Bioprocess Technology-based products.
Europe
is also drawing significant attention from the global market by providing
excellent infrastructure for research and development in this sector. However,
the APAC is the fastest growing region and is touted to influence the market
considerably in coming years. Growing population and revamped healthcare sector
can provide the much-needed thrust to the regional market.
Market Insight:
Strategies
employed by the bigshots in the sector help in both individual and holistic
growth of the Bioprocess Technology market. These strategies include mergers,
acquisitions, product launch, and other methods and better the market portfolio
of companies. For instance, Charles River Laboratories has recently acquired
MPI Research, a non-clinical contract research
organization (CRO) that provides testing services to biopharmaceutical
and medical device companies across the globe. Their market rival, Thermo
Fisher Scientific, Inc. signed an agreement with Roper Technologies to acquire
Gatan, which can ensure their market profile upgradation.
Industry News:
- Novartis
and Gilead/Kite have got approval for their respective medicines Kymriah
and Yescarta, two cell-therapy biotherapeutic medicine which can
significantly trigger monoclonal antibody industry prospect.
About US:
Market
Research Future (MRFR) enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99
Hudson Street,5Th Floor, New York,
New
York 10013
No comments:
Post a Comment